Autoimmunity in Waldenström's macroglobulinaemia. 1999

V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
Department of Hematology, Rigshospital, University of Copenhagen, Denmark.

Fifty-seven consecutive patients with Waldenström's Macroglobuliemia were studied retrospectively for autoimmune manifestations. 28 patients or 51% (16 women and 13 men) had clinical and/or serological autoimmune manifestations, two or more of these being concomitant in 20 (12 women and 8 men). The predominant findings were Coombs' positive autoimmune hemolytic anemia (16%), seropositive rheumatoid arthritis (16%), inflammatory gastric ulcer with parietal cell autoantibodies (12%), and IgM-cardiolipin syndrome (11%). 40% of the autoimmune manifestations were present at the time of diagnosis of the Waldenström's Macroglobulinaemia and 60% were observed over a mean period of 4.7 years. All patients had an IgM M-component. There was no correlation between autoimmunity and the size of the M-component or the degree of hypo-IgG and hypo-IgA gammaglobulinemia. The only correlation between autoimmunity and infection was found in patients with gastric ulcer and parietal cell autoantibodies, in whom the infection was caused by Helicobacter pylori.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008258 Waldenstrom Macroglobulinemia A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity. Lymphoma, Lymphoplasmacytoid,Macroglobulinemia,Familial Waldenstrom's Macroglobulinaemia,Lymphoma, Lymphocytic, Plasmacytoid,Primary Macroglobulinemia,Waldenstrom's Macroglobulinaemia,Waldenstrom's Macroglobulinemia,Familial Waldenstrom Macroglobulinaemia,Familial Waldenstroms Macroglobulinaemia,Lymphomas, Lymphoplasmacytoid,Lymphoplasmacytoid Lymphoma,Lymphoplasmacytoid Lymphomas,Macroglobulinaemia, Familial Waldenstrom's,Macroglobulinaemia, Waldenstrom's,Macroglobulinemia, Primary,Macroglobulinemia, Waldenstrom,Macroglobulinemia, Waldenstrom's,Waldenstrom Macroglobulinaemia,Waldenstrom's Macroglobulinaemia, Familial,Waldenstroms Macroglobulinaemia,Waldenstroms Macroglobulinemia
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities

Related Publications

V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
September 2002, Blood reviews,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
August 1985, Lancet (London, England),
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
September 2003, Clinical and experimental dermatology,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
July 1999, British journal of haematology,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
November 1979, Journal of the Royal Society of Medicine,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
March 1974, Journal of the neurological sciences,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
March 1999, British journal of haematology,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
January 2005, Clinical and experimental dermatology,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
June 1957, Proceedings of the Royal Society of Medicine,
V Jønsson, and A Kierkegaard, and S Salling, and S Molander, and L P Andersen, and M Christiansen, and A Wiik
August 2020, Acta dermato-venereologica,
Copied contents to your clipboard!